{"container_type": "Publication", "source": "AUTHOR_PUBLICATION_ENTRY", "bib": {"title": "Parenteral methotrexate: effective shelf\u2010life following initial puncture of preservative\u2010protected vial", "pub_year": 1995, "citation": "Arthritis & Rheumatism: Official Journal of the American College of \u2026, 1995", "author": "Patricia G Hunt and Carlos D Rose and Chris Smith", "journal": "Arthritis & Rheumatism: Official Journal of the American College of Rheumatology", "volume": "38", "number": "4", "pages": "575-575", "publisher": "John Wiley & Sons, Inc.", "abstract": "We read with interest the letter by Dr. McLaughlin comparing the cost of parenteral and oral methotrexate (McLaughlin GE: Parenteral versus oral methotrexate: a cost comparison [letter]. Arthritis Rheum 37: 779, 1994) and the reply by Dr. Wase (Wase LC: Reply [letter]. Arthritis Rheum 37: 779, 1994). In our pediatric rheumatology division, we have also been encouraging patients, especially those whose arthritis is refractory to oral methotrexate, to utilize the intramuscular or subcutaneous route of administration.Important issues that we have encountered and did not see addressed in the previous letters are the use of a multidose, preservative-protected vial of methotrexate (a means of further cost-containment) and the shelf-life of this product. We contacted Lederle Laboratories, whereupon we were informed in a communication by letter,\u201cFollowing initial puncture, they [Methotrexate Sodium Liquid, Preservative \u2026"}, "filled": true, "author_pub_id": "zILvqgkAAAAJ:2-lh8vUrSjUC", "num_citations": 1, "citedby_url": "/scholar?hl=en&cites=17300118001900943262", "cites_id": ["17300118001900943262"], "pub_url": "https://onlinelibrary.wiley.com/doi/abs/10.1002/art.1780380423", "url_related_articles": "/scholar?oi=bibs&hl=en&q=related:nnelq6ldFvAJ:scholar.google.com/", "cites_per_year": {"1996": 1}}